CRISPR/Cas9 knockout of Ptgs2 promotes apoptosis of hepatic stellate cells - 27/04/24
Doi : 10.1016/j.clinre.2024.102345
Hongyu Zhou a, #, Yongzhao Wang b, #, Gaoli Zhu a, Shuai Yuan a, Mingliang Liu a, Yeqing Chen a, Mingwei Han a, ⁎ 
, Xuefeng Yang c, d, ⁎
, Xuefeng Yang c, d, ⁎ a Department of Gastroenterology, 922nd Hospital of Joint Logistics Support Force, PLA, Hengyang, China
b Department of Gastroenterology, Puyang People's Hospital, Puyang, China
c Hunan Provincial Clinical Research Center for Metabolic Associated Fatty Liver Disease, the Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China
d Department of Gastroenterology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China
⁎Corresponding authors.
Abbreviations : ALP, ECM, HSCS, Α-SMA, Ptgs2, COX-2
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2024
Elsevier Masson SAS. Tutti i diritti riservati.
Vol 48 - N° 6
Articolo 102345- Giugno 2024 Ritorno al numero
Articolo precedente
- The prognostic nutritional index as a predictor of efficacy and early recurrence for adjuvant transarterial chemoembolization in hepatocellular carcinoma
- Xinting Pan, En Hu, Yang Zhou, Ling Li, Xinhui Huang, Zhixiong Cai
- Separating the effects of early and later life body mass index on liver diseases: A Mendelian randomization study
- Feixiang Zhou, Xia Liu, Canyan Chang, Jing Liu, Simin He, Yan Yan
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?